Video

Team Approach to Lung Cancer Care Is Essential

For High-Definition, Click

The proper treatment of patients with lung cancer is dependent on a team approach, emphasizes Corey J. Langer, MD. Adequate sampling and testing requires collaboration between medical oncologists, surgeons, radiologists, and thoracic pathologists. Targeted therapies have also increased the involvement of other specialties, including interventional pulmonology and interventional radiology.

With the growing number of specialists involved in the treatment of patients with lung cancer, oncologist must make it clear which tests are needed to ensure that tissue is appropriately prepared and processed, Langer notes. Moreover, the role of nurses and other support staff remains an important piece of the care continuum, particularly for their role in the education of patients and side effect monitoring.

Related Videos
Cedric Pobel, MD
Steven H. Lin, MD, PhD
Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology), professor, pharmacology, deputy director, Yale Cancer Center; chief, Hematology/Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital; assistant dean, Translational Research, Yale School of Medicine
Haley M. Hill, PA-C, discusses the role of multidisciplinary management in NRG1-positive non–small cell lung cancer and pancreatic cancer.
Haley M. Hill, PA-C, discusses preliminary data for zenocutuzumab in NRG1 fusion–positive non–small cell lung cancer and pancreatic cancer.
Haley M. Hill, PA-C, discusses how physician assistants aid in treatment planning for NRG1-positive non–small cell lung cancer and pancreatic cancer.
Haley M. Hill, PA-C, discusses DNA vs RNA sequencing for genetic testing in non–small cell lung cancer and pancreatic cancer.
Haley M. Hill, PA-C, discusses current approaches and treatment challenges in NRG1-positive non–small cell lung cancer and pancreatic cancer.
Jessica Donington, MD, MSCR, Melina Elpi Marmarelis, MD, and Ibiayi Dagogo-Jack, MD, on the next steps for biomarker testing in NSCLC.
Jessica Donington, MD, MSCR, Melina Elpi Marmarelis, MD, and Ibiayi Dagogo-Jack, MD, on tissue and liquid biopsies for biomarker testing in NSCLC.